公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

首页
技术中心
产品文献

或

货号	产品名称	文献标题	IF	杂志名称
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	Biphasic activation of nuclear factor-κB and expression of p65 and c-Rel following traumatic neuronal injury	3	Int J Mol Med
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	Oxidative stress-induced mitophagy is suppressed by the miR-106b-93-25 cluster in a protective manner	8	Cell Death & Disease
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	XBP1 modulates endoplasmic reticulum and mitochondria crosstalk via regulating NLRP3 in renal ischemia/reperfusion injury	7	cell death discovery
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	Characterization of starvation response‐related genes for predicting prognosis in breast cancer	6	Cancer Science
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	Upregulation of antioxidant and autophagy pathways via NRF2 activation protects spinal cord neurons from ozone damage	2	Mol Med Rep
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	MiR-125b regulates the proliferation and metastasis of triple negative breast cancer cells via the Wnt/β-catenin pathway and EMT	1	Bioscience, Biotechnology, and Biochemistry
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC	7	J Exp Clin Cancer Res
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	Parkin-Dependent Mitophagy Is Required for the Inhibition of ATF4 on NLRP3 Inflammasome Activation in Cerebral Ischemia-Reperfusion Injury in Rats	6	Cells,, 8, 897
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	R203M/D377Y Mutation of SAR-CoV-2 N Protein Enhancing its Immunosuppressive Activity and Promoting Viral Infection		SSRN
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	NGF-Induced Nav1. 7 Upregulation Contributes to Chronic Post-surgical Pain by Activating SGK1-Dependent Nedd4-2 Phosphorylation	4	Mol Neurobiol

首页上一页 175 176 177 178 179 180 下一页尾页

赋能细胞研究与治疗 Enabling cell research and therapy

联系我们

全国服务热线： 400-6800-830

订购邮箱： service@abbkine.com

联系地址：武汉光谷生物医药加速器17号楼1号房2-3层

友情链接：

Copyright ©Abbkine Scientific Co., Ltd- 鄂ICP备10204150号-5

意见反馈

 在线咨询

扫码关注

微信公众号

返回顶部